By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today announced the two-year extension of contracts previously awarded under the North West/South West and Wales regional forensic tender process in the UK.

The contracts, originally awarded in April 2008, were set to expire in 2011 and have been extended to 2013. In total, the contracts have a value of about $10 million, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.